UCSF Cancer Specialist Recognized with Luminary Award for Gastrointestinal Cancers

Alan P. Venook MD, a renowned expert in colorectal and liver cancers, has been announced as one of the winners of the 2022 Luminary Awards in Gastrointestinal (GI) Cancers. Venook is being recognized for his achievements in the clinical practice and research of gastrointestinal cancers. Venook is a

“CAR Pooling” Screens Identify Most Effective Cancer Immunotherapy Cells

In recent years, genetically re-engineered immune cells – armed with molecular weaponry to recognize and destroy tumor cells – have changed the landscape of cancer treatment. Now, UC San Francisco researchers have developed a new method for comparing massive numbers of these CAR-T cells, each with

Can Gut Microbes Impact Chemotherapy? So Far, the Answer is “Yes.”

Bacteria in our guts play a significant role in how we digest what we eat, and what we eat includes oral medications we take. But the gut microbiome’s impact on drugs may be different from its impact on food because drugs are often intended to target a specific tissue or organ or process in the body

UCSF Study Sheds Light on the Reasons Behind Sex Differences in Myocarditis

In the past several years, myocarditis has been of public interest because of cases associated with vaccines for SARS-CoV2 or related conditions. Another form of myocarditis has been linked to immune checkpoint inhibitors (ICIs) used in cancer care. ICI-induced myocarditis is a potentially fatal

Community Car Show Brings Cancer Screening Awareness to Mission Bay

UCSF Hosts First Lady Jill Biden to Discuss Breast Cancer Research

First Lady Jill Biden, PhD, met with top UC San Francisco cancer leaders during a visit Friday to hear about UCSF’s breast cancer research and progress on the National Cancer Moonshot. The visit was timed to mark Breast Cancer Awareness Month in October. Hosted by Alan Ashworth, PhD, FRS, president

NIH initiative to systematically investigate and establish function of every human gene

The National Institutes of Health is launching a program to better understand the function of every human gene and generate a catalog of the molecular and cellular consequences of inactivating each gene. The Molecular Phenotypes of Null Alleles in Cells (MorPhiC) program, managed by the National